5-Methoxy-1-methyl-uracil | 1671-13-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-Methoxy-1-methyl-uracil
• 英文别名: 5-methoxy-1-methyl-1H-pyrimidine-2,4-dione；5-Methoxy-1-methylpyrimidine-2,4-dione
• CAS: 1671-13-2
• 化学式: C₆H₈N₂O₃
• 分子量: 156.141
• InChiKey: WDTCCGGZAFTZSV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  58.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-Methoxy-1-methyl-uracil 生成 1-methyl-5-chlorouracil
  参考文献：
  名称：

  KONG, THOO LIN PAUL V. S.;BROWN, D. M., NUCLEOSIDES AND NUCLEOTIDES, 8,(1989) N-6, C. 871-874

  摘要：

  DOI：

文献信息

• [EN] OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF<br/>[FR] COMPOSITIONS D'OLIGONUCLÉOTIDES ET PROCÉDÉS ASSOCIÉS
  申请人：WAVE LIFE SCIENCES LTD

  公开号：WO2022099159A1

  公开（公告）日：2022-05-12

  Among other things, the present disclosure provides oligonucleotides and compositions thereof. In some embodiments, provided oligonucleotides and compositions are useful for adenosine modification. In some embodiments, the present disclosure provides methods for treating various conditions, disorders or diseases that can benefit from adenosine modification.

  除其他事项外，本公开提供寡核苷酸及其组合物。在某些实施例中，提供的寡核苷酸及其组合物对腺苷修饰有用。在某些实施例中，本公开提供了治疗各种需要腺苷修饰的疾病、疾病或病症的方法。
• CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND THE USES THEREOF
  申请人：Purdue Pharma LP

  公开号：EP2880033B1

  公开（公告）日：2020-06-17
• ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
  申请人：Moderna Therapeutics, Inc.

  公开号：EP3157573A2

  公开（公告）日：2017-04-26
• [EN] ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF<br/>[FR] MOLÉCULES D'ACIDE NUCLÉIQUE ALTERNATIVES ET LEURS UTILISATIONS
  申请人：MODERNA THERAPEUTICS INC

  公开号：WO2015196128A2

  公开（公告）日：2015-12-23

  The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
• [EN] OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF<br/>[FR] COMPOSITIONS D'OLIGONUCLÉOTIDES ET LEURS PROCÉDÉS D'UTILISATION
  申请人：WAVE LIFE SCIENCES LTD

  公开号：WO2021071858A1

  公开（公告）日：2021-04-15

  Among other things, the present disclosure provides oligonucleotides and compositions thereof. In some embodiments, provided oligonucleotides and compositions are useful for adenosine modification. In some embodiments, the present disclosure provides methods for treating various conditions, disorders or diseases that can benefit from adenosine modification.